Regarding the target users, it should be further noted that, although adults with type 2 diabetes (T2D) have, on average, higher age and BMI than the adult T1D population in Sweden (28), they still exhibit similar characteristics as patient groups (e.g., high blood glucose levels, increasing rates of obesity) and some patients with T2D are treated with insulin. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.